2,271 Shares in Astera Labs, Inc. $ALAB Purchased by Stephens Inc. AR

Stephens Inc. AR bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, HoldingsChannel reports. The firm bought 2,271 shares of the company’s stock, valued at approximately $378,000.

A number of other institutional investors have also added to or reduced their stakes in the company. DNB Asset Management AS grew its position in Astera Labs by 164.9% during the fourth quarter. DNB Asset Management AS now owns 25,813 shares of the company’s stock worth $4,294,000 after buying an additional 16,067 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its position in Astera Labs by 11,529.1% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 38,376 shares of the company’s stock worth $6,384,000 after buying an additional 38,046 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich grew its position in Astera Labs by 22.6% during the fourth quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,152 shares of the company’s stock worth $358,000 after buying an additional 397 shares in the last quarter. Allworth Financial LP boosted its holdings in Astera Labs by 3.8% during the fourth quarter. Allworth Financial LP now owns 3,154 shares of the company’s stock valued at $525,000 after purchasing an additional 116 shares in the last quarter. Finally, Freemont Management S.A. boosted its holdings in Astera Labs by 693.6% during the fourth quarter. Freemont Management S.A. now owns 111,900 shares of the company’s stock valued at $18,616,000 after purchasing an additional 97,800 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the transaction, the director owned 319,863 shares in the company, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of Astera Labs stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. This trade represents a 7.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 1,915,461 shares of company stock worth $358,508,976. Insiders own 12.50% of the company’s stock.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Evercore ISI raised its price target on Astera Labs to $297 from $215 and kept an Outperform rating after updated AI channel checks, reinforcing the market’s view that ALAB is benefiting from strong AI infrastructure demand. Article Title
• Positive Sentiment: Multiple reports point to momentum from the AI inference boom, with traders and investors buying into the stock after bullish coverage, elevated call activity, and a “golden cross” technical breakout that can attract trend-following buyers. Article Title
• Positive Sentiment: Recent commentary highlighted Astera Labs as a beneficiary of rising AI infrastructure spending, supporting the stock’s move higher and helping it reach fresh highs. Article Title
• Neutral Sentiment: Executives including the CEO, COO, and general counsel disclosed large share sales, but several transactions were tied to pre-arranged 10b5-1 plans or tax withholding on equity awards, which makes the selling less conclusive as a bearish signal. Article Title

Astera Labs Trading Up 3.0%

NASDAQ ALAB opened at $306.88 on Friday. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $315.81. The stock’s 50 day moving average is $170.39 and its two-hundred day moving average is $159.79. The company has a market capitalization of $52.60 billion, a price-to-earnings ratio of 207.35, a PEG ratio of 3.94 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the previous year, the company posted $0.33 earnings per share. Astera Labs’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on ALAB. Citigroup lifted their price objective on Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. TD Cowen lifted their price objective on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. UBS Group began coverage on Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective on the stock. Jefferies Financial Group reaffirmed a “buy” rating and set a $270.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Finally, Barclays lifted their price objective on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $233.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.